X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Nicole Longo

Nicole Longo Nicole is senior manager of public affairs at PhRMA. She previously worked for a D.C.-based public affairs firm where she assisted a wide range of clients with communications efforts on everything from trade policy to agriculture policy to health care policy. Outside the office, Nicole can be found trying new restaurants (usually Italian), taking an occasional barre class and cheering on the Cincinnati Bengals.

Recent Posts

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

By Nicole Longo  |    May 22, 2017
We often discuss the creation of Part D when we talk about the market-based changes that the Medicare Modernization Act (MMA) made to Medicare, but that’s just one example. Today, let’s take a...   Read More

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

By Nicole Longo  |    May 15, 2017
We’ve talked a lot about how repealing the non-interference clause in Medicare Part D would negatively impact beneficiaries. But there are other proposals to fundamentally alter the structure of...   Read More

Former law enforcement officials raise concerns with drug importation proposals

By Nicole Longo  |    May 11, 2017
Time and again, proponents of drug importation schemes overlook the major impact such proposals would have on our law enforcement officers – the men and women who spend their lives protecting...   Read More

Medicare Monday: How finding an Alzheimer’s treatment could lower Medicare spending

By Nicole Longo  |    May 8, 2017
Alzheimer’s disease is devastating and impacts more than 5.5 million Americans and their families. While America’s biopharmaceutical researchers have been working tirelessly to find a cure for the...   Read More

Medicare Monday: What the experts are saying about the Independent Payment Advisory Board

By Nicole Longo  |    May 1, 2017
The Independent Payment Advisory Board (IPAB), a panel of 15 members selected by the President and confirmed by the Senate, is tasked with proposing cuts to Medicare if spending exceeds a certain...   Read More

Medicare Monday: Stakeholders raise concern with MedPAC’s proposed changes to drug purchasing program

By Nicole Longo  |    April 24, 2017
A couple weeks ago, we looked at what a broad group of stakeholders have said about the recommended changes to Part B that the Medicare Payment Advisory Commission (MedPAC) voted in support of....   Read More

Medicare Monday: Another example of the competitive market at work in Part D

By Nicole Longo  |    April 17, 2017
Hepatitis C is a devastating viral disease that can result in life-threatening and costly complications. Five years ago, the only available treatment for the disease often resulted in debilitating...   Read More

Medicare Monday: What they are saying about MedPAC’s Part B recommendations

By Nicole Longo  |    April 10, 2017
Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients’ access to Part...   Read More

Resources for understanding the dangers of drug importation

By Nicole Longo  |    March 28, 2017
Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively...   Read More

Medicare Monday: A discussion on affordability and access to medicines

By Nicole Longo  |    March 27, 2017
In case you missed it, the American Society on Aging held its annual conference last week in Chicago, IL, where Lori Reilly, PhRMA executive vice president of policy, research & membership, spoke...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates